Pay in 4 interest-free payments of $5.80 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
TRICARE did not cover these drugs for weight loss alone, but rather to improve medical conditions associated with obesity
To date, these GLP-1 drugs have been approved to treat three adult populations: individuals with type 2 diabetes, individuals with a body mass index (BMI) of 30 or greater (obesity), and individuals with a BMI between 27 and 30 (overweight) with at least one weight-related health condition, such as cardiovascular disease, high blood pressure, high cholesterol, prior stroke, prior heart attack, and chest pain (angina)
Subramanian et al., 2013)
C.ZhaoN.FuY.WangN.LinaresC.TsaiC
US$ 22.94
US$ 23.36
US$ 25.62
US$ 22.97
US$ 25.22
US$ 23.23
US$ 22.55
US$ 24.04
US$ 28.88
US$ 27.93
US$ 23.36
